IOL Chemicals And Pharmaceuticals, 524164, IOLCP Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,827.50
18.79
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,805.04
1.61%
1.09

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

18.68
2.40
-0.79

EBITDA CAGR (%)

10 Years
5 Years
3 Years

35.29
-16.60
-2.24

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-17.82
-7.10

P:E (Median)

8 Years
5 Years
3 Years

16.77
16.77
16.77

P:BV (Average)

8 Years
5 Years
3 Years

1.47
1.47
1.47

EV:EBITDA (Average)

8 Years
5 Years
3 Years

8.80
8.80
8.80

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 523.30 520.39 0.56% 525.75 545.30 -3.59% 502.38 563.18 -10.80% 503.92 587.21 -14.18%
Expenses 476.43 475.91 0.11% 484.19 481.20 0.62% 451.58 490.32 -7.90% 453.84 491.42 -7.65%
EBITDA 46.87 44.48 5.37% 41.56 64.10 -35.16% 50.80 72.86 -30.28% 50.08 95.79 -47.72%
EBIDTM 8.96% 8.55% 7.90% 11.76% 10.11% 12.94% 9.94% 16.31%
Other Income 4.07 8.38 -51.43% 6.43 7.11 -9.56% 7.38 7.06 4.53% 7.52 8.72 -13.76%
Interest 4.46 4.30 3.72% 4.12 4.44 -7.21% 2.15 3.95 -45.57% 3.41 4.88 -30.12%
Depreciation 18.66 16.32 14.34% 17.93 15.67 14.42% 16.80 14.44 16.34% 16.42 12.10 35.70%
PBT 27.82 32.24 -13.71% 25.94 51.10 -49.24% 39.23 61.53 -36.24% 37.77 87.53 -56.85%
Tax 7.27 9.01 -19.31% 6.79 13.31 -48.99% 9.55 15.32 -37.66% 9.58 22.26 -56.96%
PAT 20.55 23.23 -11.54% 19.15 37.79 -49.33% 29.68 46.21 -35.77% 28.19 65.27 -56.81%
PATM 3.93% 4.46% 3.64% 6.93% 5.91% 8.21% 5.59% 11.12%
EPS 0.70 0.79 -11.39% 0.65 1.29 -49.61% 1.01 1.57 -35.67% 0.96 2.22 -56.76%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 523.30 520.39 0.56% 525.75 545.30 -3.59% 502.38 563.18 -10.80% 503.92 587.21 -14.18%
Expenses 476.43 476.04 0.08% 484.18 481.10 0.64% 451.27 490.66 -8.03% 454.40 491.91 -7.63%
EBITDA 46.87 44.35 5.68% 41.57 64.20 -35.25% 51.11 72.52 -29.52% 49.52 95.30 -48.04%
EBIDTM 8.96% 8.52% 7.91% 11.77% 10.17% 12.88% 9.83% 16.23%
Other Income 4.07 8.38 -51.43% 6.43 7.11 -9.56% 7.38 7.06 4.53% 7.52 8.73 -13.86%
Interest 4.46 4.30 3.72% 4.12 4.44 -7.21% 2.15 3.95 -45.57% 3.41 4.88 -30.12%
Depreciation 18.68 16.34 14.32% 17.94 15.69 14.34% 16.82 14.45 16.40% 16.43 12.11 35.67%
PBT 27.80 32.09 -13.37% 25.94 51.18 -49.32% 39.52 61.18 -35.40% 37.20 87.04 -57.26%
Tax 7.27 9.01 -19.31% 6.79 13.31 -48.99% 9.55 15.32 -37.66% 9.58 22.26 -56.96%
PAT 20.53 23.08 -11.05% 19.15 37.87 -49.43% 29.97 45.86 -34.65% 27.62 64.78 -57.36%
PATM 3.92% 4.44% 3.64% 6.94% 5.97% 8.14% 5.48% 11.03%
EPS 0.70 0.79 -11.39% 0.65 1.29 -49.61% 1.02 1.56 -34.62% 0.94 2.21 -57.47%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 2,055.35 2,132.79 2,217.11 2,184.02 1,966.98 1,894.47 1,685.33 983.30 710.65 580.42 384.73 Net Sales Growth -7.25% -3.80% 1.52% 11.03% 3.83% 12.41% 71.40% 38.37% 22.44% 50.86% Cost Of Goods Sold 1,368.58 1,396.95 1,547.09 1,570.51 1,102.84 1,065.01 1,047.25 695.28 477.40 416.20 279.34 Gross Profit 686.77 735.84 670.02 613.51 864.14 829.46 638.08 288.02 233.25 164.21 105.38 GP Margin 33.41% 34.50% 30.22% 28.09% 43.93% 43.78% 37.86% 29.29% 32.82% 28.29% 27.39% Total Expenditure 1,866.04 1,901.27 1,990.59 1,927.74 1,375.14 1,320.59 1,275.68 863.77 608.45 529.04 373.46 Power & Fuel Cost - 149.05 131.98 78.18 51.46 65.12 63.94 45.66 37.45 46.57 48.58 % Of Sales - 6.99% 5.95% 3.58% 2.62% 3.44% 3.79% 4.64% 5.27% 8.02% 12.63% Employee Cost - 201.02 168.21 141.30 115.55 97.20 78.43 56.10 43.18 35.13 24.72 % Of Sales - 9.43% 7.59% 6.47% 5.87% 5.13% 4.65% 5.71% 6.08% 6.05% 6.43% Manufacturing Exp. - 47.67 43.07 36.86 28.13 28.37 25.68 22.57 16.77 8.83 4.55 % Of Sales - 2.24% 1.94% 1.69% 1.43% 1.50% 1.52% 2.30% 2.36% 1.52% 1.18% General & Admin Exp. - 9.00 6.52 5.12 4.48 2.86 2.63 1.39 1.19 1.17 1.40 % Of Sales - 0.42% 0.29% 0.23% 0.23% 0.15% 0.16% 0.14% 0.17% 0.20% 0.36% Selling & Distn. Exp. - 51.25 61.85 66.84 50.78 48.45 46.72 33.73 20.81 12.81 6.39 % Of Sales - 2.40% 2.79% 3.06% 2.58% 2.56% 2.77% 3.43% 2.93% 2.21% 1.66% Miscellaneous Exp. - 46.33 31.87 28.93 21.90 13.58 11.03 9.04 11.65 8.33 6.39 % Of Sales - 2.17% 1.44% 1.32% 1.11% 0.72% 0.65% 0.92% 1.64% 1.44% 2.20% EBITDA 189.31 231.52 226.52 256.28 591.84 573.88 409.65 119.53 102.20 51.38 11.27 EBITDA Margin 9.21% 10.86% 10.22% 11.73% 30.09% 30.29% 24.31% 12.16% 14.38% 8.85% 2.93% Other Income 25.40 30.07 25.57 32.04 24.30 16.02 10.37 6.33 1.25 1.23 1.32 Interest 14.14 16.10 16.47 8.29 5.83 20.93 51.42 64.35 67.68 61.47 59.11 Depreciation 69.81 62.85 46.13 43.26 38.92 35.73 32.45 30.21 29.84 29.69 28.91 PBT 130.76 182.64 189.49 236.77 571.39 533.24 336.15 31.30 5.93 -38.55 -75.44 Tax 33.19 47.22 49.51 57.18 126.83 171.95 99.45 3.60 1.26 1.48 -8.79 Tax Rate 25.38% 25.85% 26.13% 25.66% 22.20% 32.25% 29.59% 11.50% 21.25% -3.84% 11.65% PAT 97.57 135.42 139.98 165.66 444.56 361.29 236.70 27.70 4.67 -40.03 -66.65 PAT before Minority Interest 97.57 135.42 139.98 165.66 444.56 361.29 236.70 27.70 4.67 -40.03 -66.65 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.75% 6.35% 6.31% 7.59% 22.60% 19.07% 14.04% 2.82% 0.66% -6.90% -17.32% PAT Growth -43.44% -3.26% -15.50% -62.74% 23.05% 52.64% 754.51% 493.15% - - EPS 3.32 4.61 4.77 5.64 15.15 12.31 8.06 0.94 0.16 -1.36 -2.27

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 2,055.35 2,132.79 2,217.11 2,184.02 Net Sales Growth -7.25% -3.80% 1.52% Cost Of Goods Sold 1,368.58 1,396.95 1,547.09 1,570.51 Gross Profit 686.77 735.84 670.02 613.51 GP Margin 33.41% 34.50% 30.22% 28.09% Total Expenditure 1,866.28 1,902.20 1,991.44 1,925.73 Power & Fuel Cost - 149.05 131.98 78.18 % Of Sales - 6.99% 5.95% 3.58% Employee Cost - 201.02 168.21 141.30 % Of Sales - 9.43% 7.59% 6.47% Manufacturing Exp. - 47.67 43.07 36.86 % Of Sales - 2.24% 1.94% 1.69% General & Admin Exp. - 9.01 6.54 5.12 % Of Sales - 0.42% 0.29% 0.23% Selling & Distn. Exp. - 51.25 61.85 66.84 % Of Sales - 2.40% 2.79% 3.06% Miscellaneous Exp. - 47.25 32.70 26.92 % Of Sales - 2.22% 1.47% 1.23% EBITDA 189.07 230.59 225.67 258.29 EBITDA Margin 9.20% 10.81% 10.18% 11.83% Other Income 25.40 30.07 25.61 32.04 Interest 14.14 16.10 16.47 8.29 Depreciation 69.87 62.91 46.16 43.26 PBT 130.46 181.65 188.65 238.78 Tax 33.19 47.22 49.51 57.18 Tax Rate 25.44% 26.00% 26.24% 25.43% PAT 97.27 134.43 139.14 167.67 PAT before Minority Interest 97.27 134.43 139.14 167.67 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 4.73% 6.30% 6.28% 7.68% PAT Growth -43.31% -3.39% -17.02% EPS 3.31 4.58 4.74 5.71

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,611.33 1,506.55 1,390.27 1,260.43 813.54 474.34 215.74 188.70 185.13 207.20 Share Capital 58.71 58.71 58.71 58.71 56.89 56.89 56.21 56.21 56.21 47.66 Total Reserves 1,552.62 1,447.84 1,331.56 1,201.72 747.33 408.13 159.53 132.49 128.92 153.56 Non-Current Liabilities 72.89 58.15 56.62 59.11 79.73 210.65 280.29 294.23 304.43 285.87 Secured Loans 0.00 0.00 0.00 0.00 0.00 189.88 236.16 262.37 283.25 253.84 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 21.96 22.61 18.62 23.26 Long Term Provisions 6.71 1.65 3.01 3.68 3.85 4.59 2.04 1.50 1.18 0.30 Current Liabilities 596.85 502.17 575.29 432.80 453.63 324.79 350.97 327.67 282.92 208.54 Trade Payables 469.18 314.22 409.29 238.83 180.38 120.27 157.61 149.84 115.68 70.25 Other Current Liabilities 54.42 53.93 54.02 41.00 34.46 63.88 50.97 35.84 30.03 17.81 Short Term Borrowings 32.76 79.63 42.75 0.00 55.92 67.72 135.27 140.77 137.09 120.44 Short Term Provisions 40.49 54.39 69.23 152.97 182.87 72.92 7.12 1.22 0.13 0.04 Total Liabilities 2,281.07 2,066.87 2,022.18 1,752.34 1,346.90 1,009.78 847.00 810.60 772.48 701.61 Net Block 932.69 751.31 560.64 512.36 469.04 411.72 405.64 373.88 399.50 402.82 Gross Block 1,236.41 994.71 761.99 677.69 595.78 503.91 465.53 403.77 619.96 594.29 Accumulated Depreciation 303.72 243.40 201.35 165.33 126.74 92.19 59.89 29.89 220.47 191.47 Non Current Assets 1,124.49 1,101.54 881.58 600.19 498.99 457.60 416.02 395.94 415.63 418.12 Capital Work in Progress 100.87 89.64 105.20 48.27 19.19 27.02 6.95 21.26 4.31 4.21 Non Current Investment 17.71 17.71 0.10 0.00 0.00 0.00 0.00 0.05 0.04 0.04 Long Term Loans & Adv. 23.62 9.52 10.77 17.61 1.33 11.56 1.26 0.38 9.01 10.75 Other Non Current Assets 49.60 233.36 204.87 21.95 9.43 7.30 2.17 0.37 2.77 0.30 Current Assets 1,156.58 965.33 1,140.60 1,152.15 847.91 552.18 430.98 414.66 356.86 283.49 Current Investments 2.88 2.56 2.37 1.22 0.05 0.06 0.06 0.05 0.05 0.01 Inventories 424.84 325.52 409.89 295.15 187.52 188.86 207.45 262.63 227.94 213.42 Sundry Debtors 471.23 505.28 469.80 300.31 272.42 199.16 146.14 112.77 87.26 32.67 Cash & Bank 142.62 20.90 137.88 364.74 154.65 29.60 17.32 16.81 11.94 12.70 Other Current Assets 115.01 22.18 30.99 38.52 233.27 134.50 60.01 22.40 29.67 24.68 Short Term Loans & Adv. 90.10 88.89 89.67 152.21 208.87 126.88 56.79 18.79 26.78 22.19 Net Current Assets 559.73 463.16 565.31 719.35 394.28 227.39 80.01 86.99 73.93 74.95 Total Assets 2,281.07 2,066.87 2,022.18 1,752.34 1,346.90 1,009.78 847.00 810.60 772.49 701.61

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,611.51 1,507.72 1,392.28 Share Capital 58.71 58.71 58.71 Total Reserves 1,552.80 1,449.01 1,333.57 Non-Current Liabilities 72.89 58.15 56.62 Secured Loans 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 6.71 1.65 3.01 Current Liabilities 597.10 502.52 575.29 Trade Payables 469.18 314.22 409.29 Other Current Liabilities 54.67 54.28 54.02 Short Term Borrowings 32.76 79.63 42.75 Short Term Provisions 40.49 54.39 69.23 Total Liabilities 2,281.50 2,068.39 2,024.19 Net Block 933.13 751.81 560.64 Gross Block 1,236.94 995.24 761.99 Accumulated Depreciation 303.81 243.43 201.35 Non Current Assets 1,124.63 1,101.74 881.48 Capital Work in Progress 100.87 89.64 105.20 Non Current Investment 17.41 17.41 0.00 Long Term Loans & Adv. 23.62 9.52 10.77 Other Non Current Assets 49.60 233.36 204.87 Current Assets 1,156.87 966.65 1,142.71 Current Investments 2.88 2.56 2.37 Inventories 424.84 325.52 409.89 Sundry Debtors 471.23 505.28 469.80 Cash & Bank 142.89 21.83 139.99 Other Current Assets 115.03 29.86 30.99 Short Term Loans & Adv. 90.12 81.60 89.67 Net Current Assets 559.77 464.13 567.42 Total Assets 2,281.50 2,068.39 2,024.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 290.76 123.14 91.04 379.78 470.80 273.17 119.72 83.34 17.70 -46.96 PBT 182.64 189.49 222.84 571.39 533.24 336.15 31.30 5.93 -38.55 -75.44 Adjustment 60.06 44.42 33.12 27.15 51.93 82.35 91.64 95.92 83.92 81.73 Changes in Working Capital 90.08 -63.67 -102.34 -76.51 2.78 -77.64 3.14 -17.45 -27.67 -52.83 Cash after chg. in Working capital 332.78 170.24 153.62 522.03 587.95 340.86 126.08 84.40 17.70 -46.54 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -42.02 -47.10 -62.58 -142.25 -117.15 -67.69 -6.36 -1.06 0.00 -0.42 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -191.69 -119.19 -120.62 -317.25 -184.23 -63.04 -50.38 -22.78 -27.37 -4.79 Net Fixed Assets -252.93 -217.16 -141.23 -110.99 -84.04 -58.45 -47.45 199.24 -25.77 4.03 Net Investments -0.32 -17.80 -1.25 -1.17 0.01 0.00 0.04 -0.01 -0.04 -0.05 Others 61.56 115.77 21.86 -205.09 -100.20 -4.59 -2.97 -222.01 -1.56 -8.77 Cash from Financing Activity -92.50 -4.11 -1.64 -58.28 -271.89 -197.46 -70.36 -59.78 9.27 49.69 Net Cash Inflow / Outflow 6.57 -0.16 -31.22 4.25 14.68 12.67 -1.02 0.78 -0.40 -2.07 Opening Cash & Equivalents 0.96 1.12 32.34 28.09 13.41 0.74 1.76 0.98 1.38 15.06 Closing Cash & Equivalent 7.53 0.96 1.12 32.34 28.09 13.41 0.74 1.76 0.98 12.99

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity 290.08 122.27 93.05 PBT 181.65 188.65 224.85 Adjustment 60.12 44.41 33.12 Changes in Working Capital 90.33 -63.69 -102.34 Cash after chg. in Working capital 332.10 169.37 155.63 Interest Paid 0.00 0.00 0.00 Tax Paid -42.02 -47.10 -62.58 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -191.28 -120.00 -120.52 Net Fixed Assets -252.93 -217.16 Net Investments -0.32 -17.80 Others 61.97 114.96 Cash from Financing Activity -92.50 -4.11 -1.64 Net Cash Inflow / Outflow 6.30 -1.84 -29.11 Opening Cash & Equivalents 1.39 3.23 32.34 Closing Cash & Equivalent 7.69 1.39 3.23

Financial Ratios

Standalone /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 54.89 256.61 236.80 214.69 141.36 81.74 38.38 33.57 32.94 42.22 ROA 6.23% 6.85% 8.78% 28.69% 30.66% 25.50% 3.34% 0.59% -5.43% -9.24% ROE 8.69% 9.66% 12.50% 43.06% 56.93% 69.54% 13.70% 2.50% -20.72% -34.14% ROCE 12.30% 13.64% 17.16% 54.20% 68.09% 55.53% 15.03% 11.57% 3.68% -2.78% Fixed Asset Turnover 1.91 2.52 3.03 3.09 3.45 3.48 2.30 1.51 1.06 0.73 Receivable days 83.56 80.26 64.35 53.14 45.43 37.39 47.21 47.21 33.98 35.12 Inventory Days 64.21 60.53 58.91 44.78 36.26 42.92 85.71 115.79 125.04 173.90 Payable days 102.34 85.35 75.31 69.37 41.74 37.73 62.92 46.31 3.40 9.79 Cash Conversion Cycle 45.42 55.45 47.95 28.55 39.95 42.57 69.99 116.69 155.61 199.24 Total Debt/Equity 0.02 0.05 0.03 0.00 0.07 0.61 1.96 2.37 2.44 1.99 Interest Cover 12.34 12.51 27.88 99.01 26.48 7.54 1.49 1.09 0.37 -0.28

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 54.90 256.81 237.15 ROA 6.18% 6.80% 8.28% ROE 8.62% 9.60% 12.04% ROCE 12.24% 13.57% 16.25% Fixed Asset Turnover 1.91 2.52 2.87 Receivable days 83.56 80.26 78.51 Inventory Days 64.21 60.53 68.50 Payable days 102.34 85.35 95.12 Cash Conversion Cycle 45.42 55.45 51.89 Total Debt/Equity 0.02 0.05 0.03 Interest Cover 12.28 12.45 28.12

Top Investors:

vasudeva commercials limited

g consultants and fabricators private limited

llp

Annual Reports:

News Update:

IOL Chemicals secures approval for Ibuprofen from CDE in China
29th Apr 2025, 12:12 PM

This approval authorizes the company to export Ibuprofen to the Chinese markets
Read More
IOL Chemicals commences new Unit 11 for Paracetamol production in Punjab
25th Mar 2025, 11:09 AM

The company has enhanced the installed capacity of Unit 5 for manufacturing Clopidogrel Bisulphate from 180 MTPA to 240 MT
Read More
IOL Chemicals and Pharmaceuticals gets Certificate of Suitability from EDQM
6th Mar 2025, 14:19 PM

This certification will enable the company to export Quetiapine Fumarate to European and other countries
Read More
IOL Chemicals and Pharmaceuticals reports 11% fall in Q3 consolidated net profit
13th Feb 2025, 15:28 PM

Total consolidated income of the company decreased marginally at Rs 527.37 crore for Q3FY25
Read More
IOL Chem & Pharma - Quarterly Results
12th Feb 2025, 18:05 PM

Read More

IOL Chemicals And Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

BSE: 524164 | NSE: IOLCP

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

IOL Chemicals And Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

BSE: 524164 | NSE: IOLCP

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: